Patents Assigned to Univ.
  • Patent number: 5674238
    Abstract: A perineometer which indicates the pressure created by vaginal contractions. A probe with a bulbous end is inflated inside the vagina, and a pressure transducer in fluid communication with the probe indicates the pressure of vaginal contractions to a display. The probe may be constructed with bellows. The probe may also be constructed of an elastic material having two different expansion rates.
    Type: Grant
    Filed: June 24, 1996
    Date of Patent: October 7, 1997
    Assignee: Research Foundation of the State Univ. of N.Y.
    Inventors: Steven B. Sample, Bonnie Bullough, Patricia A. Burns
  • Patent number: 5670502
    Abstract: The present invention provides methods for treating mammalian cancer tumors, preferably solid tumors, comprising administering to a mammal in need of such treatment an effective amount of a 1,2,4-benzotriazine oxide as defined in Formula I or pharmacologically acceptable salts of said compound; and administering to the mammal from about one half hour to about twenty-four hours after administering the 1,2,4-benzotriazine oxide an effective amount of a chemotherapy agent to which the minor is susceptible. The invention also provides kits for treatment of such tumors which comprise a chemotherapy agent and a cytotoxicity-enhancing amount of a 1,2,4-benzotriazine oxide as defined in Formula I.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: September 23, 1997
    Assignee: The Board of Trustees of Leland Stanford Jr. Univ.
    Inventor: J. Martin Brown
  • Patent number: 5669394
    Abstract: A fine-needle aspirator for collecting a biosample from a subject into a closed sterile system. The aspirator is adapted for use with a variety of needles and comprises a motor drive pump capable of continuous suction in a biosample collection system. The biosample collection system may comprise a biosample connector such as elastomeric tubing in communication with the needle and a collection space in a biosample container whereby a biosample collected by the needle may be transferred to the collection space. A flushing substance flushes the biosample through the biosample collection system. Additives may be added to the biosample after collection in order to treat, preserve or analyze the biosample.
    Type: Grant
    Filed: December 22, 1994
    Date of Patent: September 23, 1997
    Assignee: The Board Of Regents of the Univ. of Oklahoma
    Inventors: Karl H. Bergey, William H. Diepenbrock
  • Patent number: 5667968
    Abstract: Photoreceptor injury or cell death (retinal degeneration) is prevented by the introduction into the living mammalian eye of specific, survival-promoting factors. These specific factors prevent damage and degeneration of photoreceptors when introduced into the living eye prior to, during or after exposure to the damaging effects of light and delay photoreceptor damage caused by inherited disease.
    Type: Grant
    Filed: November 4, 1994
    Date of Patent: September 16, 1997
    Assignees: Regeneron Pharmaceuticals, Inc., Regents of the Univ. of California
    Inventors: Matthew M. LaVail, Roy H. Steinberg, George D. Yancopoulos
  • Patent number: 5663317
    Abstract: The invention provides nucleic acids encoding one or more hyper-invasive genes within the hil locus (hyper-invasion locus) or fragments thereof, methods for making attenuated microorganisms and identifying such hyper-invasive nucleic acids as well as mutant microorganisms wherein one or more hyper-invasive genes within the hil locus are modified to attenuate the invasive phenotype of the microorganism. The methods of the invention utilize conditions which repress invasiveness in an otherwise invasive microorganism. The method comprises mutating an invasive microorganism to form a plurality of mutant microorganisms. The thus formed mutants are exposed to conditions which repress invasiveness of the parental invasive microorganism. At least one mutant microorganism is then detected which exhibits an increase in invasiveness as compared to the parental invasive microorganism.
    Type: Grant
    Filed: September 1, 1994
    Date of Patent: September 2, 1997
    Assignee: The Board of Trustees of the Leland Stanford Jr. Univ.
    Inventors: Stanley Falkow, Catherine A. Lee
  • Patent number: 5660851
    Abstract: Absorbable ocular inserts fabricated of materials that are biologically inert, biodegradable, non-allergenic, and insoluble in tear liquid, and a method for delivering substances to the eye using the ocular insert, are disclosed. In embodiment A of the invention, the insert and method include the covalent attachment of a carboxylic acid-containing substance to be delivered to a polymer that contains pendent carboxylic acid groups, through anhydride linkages. The drug is released over time by hydrolysis of the anhydride bonds. In embodiment B of the invention, a substance to be delivered (whether or not it contains a carboxylic acid group) is dispersed within an anhydride polymer or copolymer matrix and the mixture is formed into an appropriately shaped article for ocular delivery.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: August 26, 1997
    Assignee: Yissum Research Development Company of the Hebrew Univ. of Jerusalem
    Inventor: Abraham Jacob Domb
  • Patent number: 5648335
    Abstract: The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
    Type: Grant
    Filed: June 4, 1996
    Date of Patent: July 15, 1997
    Assignees: Cephalon, Inc., Albert Einstein College of Medicine of Yeshiva Univ.
    Inventors: Michael E. Lewis, Stuart C. Apfel, John A. Kessler
  • Patent number: 5648058
    Abstract: The synthesis and characterization of novel molecular sieves containing bis(pentamethylcyclopentadienyl) cobalt(III) ion are described. Several types of molecular sieves were prepared using the cobalt metal complex as a template that was shown to be incorporated as a guest molecule within the molecular sieve. Molecular sieves prepared using bis(pentamethylcyclopentadienyl) cobalt(III) ion as template were characterized as having a pore size at least as large as 7 .ANG.. Other molecular sieves were also prepared using bis(cyclopentadienyl) cobalt(III) templates. The compounds are attractive as catalysts in a wide range of applications.
    Type: Grant
    Filed: May 11, 1995
    Date of Patent: July 15, 1997
    Assignee: Board of Regents, The Univ. of Texas System
    Inventors: Kenneth J. Balkus, Jr., Alexi G. Gabrielov
  • Patent number: 5646251
    Abstract: The invention provides purified ARAg polypeptides, antibodies against ARAg polypeptides and nucleic acids encoding ARAg polypeptides. Also provided are methods of diagnosis and treatment using the same. ARAg polypeptides are typically present on the surface of alloantigen-activated CD8.sup.+ T-cells, monocytes, granulocytes and peripheral dendritic cells, and substantially absent on resting T-cells, mitogen-activated CD8.sup.+ T-cells, B-cells, erythroid cell lines, myelomonocitic cell lines, EBV-LCL cell lines and fibroblastoid cell lines. An exemplary ARAg polypeptide, termed ARAg-h-1, has a signal sequence, seven variable-type immunoglobulin-like domains, a transmembrane domain and an intracellular domain.
    Type: Grant
    Filed: June 30, 1995
    Date of Patent: July 8, 1997
    Assignee: The Board of Trustees of Leeland Stanford Jr. Univ.
    Inventors: Curtis L. Ruegg, Alberto Rivas, Reiner Laus, Edgar G. Engleman
  • Patent number: 5645991
    Abstract: The present invention discloses a rapid method of restriction mapping, sequencing or localizing genetic features in a segment of deoxyribonucleic acid (DNA) that is up to 42 kb in size. The method in part comprises cloning of the DNA segment in a specialized cloning vector and then isolating nested deletions in either direction in vivo by intramolecular transposition into the cloned DNA. A plasmid has been prepared and disclosed.
    Type: Grant
    Filed: March 14, 1995
    Date of Patent: July 8, 1997
    Assignees: Univ. of Connecticut, Washington University
    Inventors: Claire M. Berg, Douglas E. Berg, Gan Wang
  • Patent number: 5639755
    Abstract: The present invention provides methods for treating Cryptococcus neoformans and Candida albicans in a subject in need of such treatment. The methods comprises administering to the subject a dicationic bis-benzimidazole in an amount effective to treat the conditions.
    Type: Grant
    Filed: May 1, 1996
    Date of Patent: June 17, 1997
    Assignees: University of North Carolina, Duke University, Georgia State Univ. Research Foundation
    Inventors: Christine C. Dykstra, John Perfect, David W. Boykin, W. David Wilson, Richard R. Tidwell
  • Patent number: 5639712
    Abstract: Quassinoid compounds, compositions, and methods of using them for treating cells and solid tumors, and inhibiting plant growth.
    Type: Grant
    Filed: November 4, 1994
    Date of Patent: June 17, 1997
    Assignees: Indiana University Foundation, Purdue Research Foundation, Bd. of Governors of Wayne State Univ.
    Inventors: Paul A. Grieco, D. James Morre, Thomas H. Corbett, Frederick A. Valeriote
  • Patent number: 5633167
    Abstract: Methods for blood sample preparation using reagent compositions which include a zwitterionic surfactant for sphering of cells to eliminate orientational noise. When the reagent composition including a dye for staining a subset of cells is reacted with a blood sample, and the reaction mixture is passed through the sensing region of a flow cytometer, the light scattered and absorbed by each cell is measured, the stained cells can be distinguished from the unstained cells, and when the cells are reticulocytes and mature erythrocytes, respectively, the volume and hemoglobin concentration of each reticulocyte or erythrocyte, and the hemoglobin content, mean cell volume, mean corpuscular hemoglobin concentration, and mean cell hemoglobin of the reticulocytes or erythrocytes are calculated from the measured cell-by-cell volume and hemoglobin concentration.
    Type: Grant
    Filed: December 22, 1994
    Date of Patent: May 27, 1997
    Assignees: Bayer Corporation, Mt. Sinai School of Medicine of the City Univ. of New York
    Inventors: Sophie S. Fan, Daniel Ben-David, Albert Cupo, Gena Fischer, Grace E. Martin, Leonard Ornstein, Gregory M. Colella
  • Patent number: 5631167
    Abstract: Improved assay methods utilizing stable, enzymatically triggered chemiluminescent 1,2-dioxetanes with improved water solubility are provided. Assays are performed by a capsule chemistry analytical assay method wherein fluid capsules comprising discrete aqueous segments containing either a chemiluminescent dioxetane reagent or an activating agent separated by an oil-based isolating fluid are flowed through a conduit, and subsequently reacted to produce light.The improvement comprises using a dioxetane substituted with two or more water-solubilizing groups disposed on the dioxetane structure to provide the chemiluminescence. Compositions comprising such a dioxetane, a non-polymeric surfactant enhancer and optionally a fluorescer, provide enhanced chemiluminescence and eliminate the problem of reagent carryover when used in assays performed on capsule chemistry analytical systems.
    Type: Grant
    Filed: July 31, 1995
    Date of Patent: May 20, 1997
    Assignees: Bayer Corporation, Board of Governors Wayne State Univ.
    Inventors: Robert F. Adolfsen, Hashem Akhavan-Tafti, Renuka De Silva, A. Paul Schaap
  • Patent number: 5628630
    Abstract: A method of designing a skeletal implant comprises measuring the width, height, and elastic modulus of the bone to be implanted, generating a macro-design of the implant based on the width and height of the bone, and determining a micro-design for the implant, based on the measured elastic modulus, to ensure that strain in the bone is kept in a range to promote bone growth and to minimize bone resorption, during functional loading. For threaded implants, the shape of the thread is chosen so that bone strain adjacent the threaded attachment surface of the implant is between about 100 and 3000 microstrain. A device for implanting into the existing bone and for attaching a dental prosthesis thereto has a crest portion, a base portion, and a configuration for securing the base portion to the existing bone.
    Type: Grant
    Filed: December 15, 1994
    Date of Patent: May 13, 1997
    Assignee: Univ. of Alabama at Birmingham
    Inventors: Carl F. Misch, Martha W. Bidez, J. Todd Strong
  • Patent number: 5625053
    Abstract: A method of isolating purified plasmid DNA includes the steps of providing cells containing plasmid DNA and lysing the cells with an alkyldimethylphosphine oxide (APO) detergent to produce a mixture, centrifuging the cell and APO mixture, reserving a supernatant containing purified plasmid DNA and isolating the purified plasmid DNA, from the supernatant. Isolation and purification occurs in the absence of hazardous materials such as phenol and chloroform. Prior to mixing, the APO detergent is preferably combined with a strong base to produce a stable solution.
    Type: Grant
    Filed: August 26, 1994
    Date of Patent: April 29, 1997
    Assignee: Board of Regents For Northern Illinois Univ.
    Inventors: Gordon C. Kresheck, Mitchell Altschuler
  • Patent number: 5624636
    Abstract: The invention is directed to improving the disinfection of dental impressions following removal from the patient's mouth and before entering the dental laboratory to prevent contamination. It involves the use of a pH-adjusted hypochlorite solution, which is highly effective in killing microorganisms, and also relatively inexpensive. Using the solution of the instant invention for disinfection causes no damage to the impression, no loss of accuracy, and does not destroy the details on the impression surface.
    Type: Grant
    Filed: November 7, 1994
    Date of Patent: April 29, 1997
    Assignee: Univ. of Texas Board of Regents
    Inventor: Richard S. Schwartz
  • Patent number: 5623423
    Abstract: An MPEG-2 decoder circuit achieves smaller circuit area, and hence lower cost, by using circuitry, including ROMs, designed to implement residue arithmetic to calculate discrete cosine transforms in a pipelined or iterative fashion. A variable-length decoder based on ROM-like PLAs parses the stream of data to separate audio from video data and to direct the necessary operations on the data elements. The decoder and data flow through the system are controlled by a conditional MOVE processor, which is implemented as a data memory.
    Type: Grant
    Filed: December 12, 1994
    Date of Patent: April 22, 1997
    Assignee: Univ. of Texas
    Inventor: G. Jack Lipovski
  • Patent number: 5622946
    Abstract: Texaphyrins are provided for use as radiation sensitizers. Advantageous properties of texaphyrins for use as a radiation sensitizer include: i) a low redox potential which allows radiation-induced hydrated electrons to flow to texaphyrin rather than neutralizing hydroxyl radicals, allowing hydroxyl radicals to cause cellular damage, ii) a relatively stable texaphyrin radical that reacts readily to covalently modify neighboring molecules causing further cellular damage, iii) intrinsic biolocalization, and iv) indifference to the presence or absence of O.sub.2. These properties allow texaphyrins to be particularly effective for treating the hypoxic areas of solid neoplasms. Methods of treatment for an individual having a neoplasm or atheroma include the use of a texaphyrin as a radiation sensitizer and as an agent for photodynamic tumor therapy, or the use of a texaphyrin for internal and for external ionizing radiation. Novel texaphyrins are provided.
    Type: Grant
    Filed: May 10, 1995
    Date of Patent: April 22, 1997
    Assignees: Pharmacyclics, Inc., Board of Regents, Univ. of Tex. Sys.
    Inventors: Jonathan L. Sessler, Anthony M. Harriman, Richard A. Miller
  • Patent number: 5619476
    Abstract: An electrostatic ultrasonic transducer formed on a semiconductor substrate by micro-machining wherein the transducer includes a silicon nitride membrane supported above the surface of the substrate by insulating supports; and the substrate and membrane define the electrodes of the transducer.
    Type: Grant
    Filed: October 21, 1994
    Date of Patent: April 8, 1997
    Assignee: The Board of Trustees of the Leland Stanford Jr. Univ.
    Inventors: Matthew I. Haller, Butrus T. Khuri-Yakub